SEC Form 4/A · accession 0001441557-17-000004

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. · CELZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.

Reporting owner

Officer — President & CEO · Director · 10% Owner

Period of report

Dec 18, 2016

Accepted (ET)

Jan 6, 2017 · 5:53 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001187953

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 18, 2016	S	3,412,791	$0.01	D	61,553,876	I	Entity
Common Stock^F1	Dec 31, 2016	S	2,935,609	$0.10	D	58,618,267	I	Entity
Common Stock	holding	—	—		—	6,466,667	D
Common Stock^F1	holding	—	—		—	64,966,667	I	Entity

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrants^F2	$0.10	holding	—	—	—	Sep 30, 2016	Sep 30, 2026	Common Stock	30,000	30,000	I

F1Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein.
F2Warrants are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein.
F3The transaction reported hereby represents a cancellation of debt owed by the reporting party to the purchaser. The total amount of debt exchanged for the common shares was $293,560.91, or $0.10 per share, the same price as shares of common stock purchased by the reporting party on September 30, 2016. As an incentive to enter into the transaction the reporting party granted to the purchaser an option to purchase up to 293,561 shares of the Issuer at $0.10 per share with such option expiring August 1, 2019.